Relative Bioavailability of Binimetinib 3 x 15 mg and 45 mg Formulations

Conditions

• Melanoma
• BRAF V600 Mutation
• Unresectable Melanoma
• Metastatic Melanoma

Interventions

• DRUG: Binimetinib Oral Tablet

Sponsor

Pierre Fabre Medicament

Collaborators

• [object Object]